Back to search

Peptide record

TPDB20913

Antibacterial Anticancer Toxicity modified_plain modified
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB20913
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
modified_plain
Yes
A 14-aa modified multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Modified, details unspecified
Sequence
GXXKKXXKKXXKKX
Physicochemical Analysis
C38H77N13O8
ARNDCEQHILMFPSTWYV
K
844.11
11.21
6
0
0
+6
5.95
-1.700
0.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
0
I
0
L
6
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 0 L: 0 K: 6 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
14
C38H77N13O8
844.11
11.21
+6
5.95
-1.700
Evidence Records 3 records
Evidence 1 Activity

Activity

30% Killing
Toxicity
40 µM
Cytotoxic
30% Killing | 40 | µM | target cell: Human keratinocytes HaCat

Target

Human keratinocytes HaCat

Source & Reference

NA
DBAASP
Amino acid side chains affect the bioactivity of designed short peptide amphiphiles | J Mater Chem B | 2016
Evidence 2 Activity

Activity

50% Hemolysis
Toxicity
30 µM
Hemolytic Cytotoxic
50% Hemolysis | 30 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Amino acid side chains affect the bioactivity of designed short peptide amphiphiles | J Mater Chem B | 2016
Evidence 3 Activity

Activity

HC50
Toxicity
30 µM
Hemolytic Cytotoxic
Hemolytic_activity: Human erythrocytes: HC50=30 µM | Cytotoxicity: Human keratinocytes HaCat: 30% Killing=40 µM

Target

erythrocytes

Source & Reference

NA
DRAMP